Pro Medicus (OTCMKTS:PMCUF) Shares Gap Up – Should You Buy?

Pro Medicus Limited (OTCMKTS:PMCUF)’s stock price gapped up prior to trading on Thursday . The stock had previously closed at $133.60, but opened at $143.4960. Pro Medicus shares last traded at $143.4960, with a volume of 328 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group cut shares of Pro Medicus from a “buy” rating to a “hold” rating in a research report on Wednesday, July 8th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $155.00.

Pro Medicus Trading Up 4.1%

The stock has a fifty day moving average of $125.53 and a two-hundred day moving average of $105.82.

About Pro Medicus

Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.

The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.